Loading viewer...
earnings
Format: PDF earnings
Q4 FY2016 earnings presentation delivered on August 17, 2016, covering the company's financial performance and fiscal 2017 outlook. Includes discussion of forward-looking statements, non-GAAP financial measures including EBITDA and Adjusted EBITDA, and risk factors as outlined in the company's SEC filings.
investor_presentation
18 Pages
earnings
17 Pages
R1 RCM
Alembic Pharmaceuticals Q3 FY26 Investor Presentation
earningsearnings
20 Pages
Alembic Pharmaceuticals